Totally agree BMD. In following these posts i learnt early on who to listen to, who to trust and who to ignore. BMD, Oaktree, etc and those that post charts that I have no idea what they mean.
This is my first foray into the share market, and hopefully I have "pulled the right rein" (thats an age give away) but when looking at the share market, 1 thing stood out more than anything - and that was to do as much research as possible into the company, and into the potential of the product.
Biotron appealed in that they had ventured into an area, the E Protein, that appears to be under investigated and understood by the wider pharma community, whilst also possibly providing a solution to despicable and deadly diseases, which may also be of huge commercial benefit.
With the introduction of Covid-19, I believe that the potential and commercialisation of the BIT stable of compounds has been brought forward substantially, which will then reflect on earlier than expected growth of HIV, HBV, Flu trials and developments. Add in the introduction of super computers and the possible backing of large pharmas looking for the "next big thing" and I don't think there is any doubt that Biotron is sitting in the box seat.
There are some very clever people running and involved with Biotron,and they have had confidence in their compounds for 20 year. My research leads me to believe that they are right to stick to their guns and that all their work will be well rewarded, sooner rather than later - as will current SH in BIT.
Time will tell, but I think Monday is going to be a good day!
BIT Price at posting:
9.5¢ Sentiment: Buy Disclosure: Held
